[Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin. 120 cases].
Level 3 - non-randomized controlled study
Prospective comparative cohort study with a non-infectious control group and severity-stratified patient groups
PubMed 9775136 · doi:10.1016/s0248-8663(97)80715-1
What was done
A prospective comparative study evaluated 160 fasting patients categorized into four groups of 40 based on C-reactive protein (CRP) concentrations: a control group (CRP < 10 mg/L) and three groups with infectious diseases of differing acute-phase severity. Total cholesterol, triglycerides, CRP levels, and complete blood cell counts were measured and compared across all groups.
What was found
Total cholesterol was significantly reduced in all three infection groups compared to the control group (P < 0.05), even in the mild inflammation cohort (mean CRP 27.6 ± 10.5 mg/L). Cholesterol was further reduced in the highest inflammation cohort (mean CRP 250 ± 73 mg/L) relative to the lowest inflammation cohort. Lymphocytopenia was present in all infection groups but did not correlate with CRP levels. No significant changes were observed in triglyceride concentrations. Exact numerical values for cholesterol and triglycerides were not reported in the abstract.
Why it matters
The findings confirm that hypocholesterolemia develops early in acute bacterial infection and scales inversely with the magnitude of the acute-phase inflammatory response.
Limits
The abstract does not provide absolute numerical concentrations or confidence intervals for lipid parameters. Causality cannot be determined from this observational design, and clinical outcomes, specific pathogen types, nutritional status, and pre-existing lipid-lowering therapies are not described.
Cited by
- supports Cholesterol components can act as acute-phase reactants that change acutely in response to stress and inflammation.